BNP Paribas Asset Management Holding S.A. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP Paribas Asset Management Holding S.A. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$4,371
+0.5%
161,057
+13.9%
0.01%0.0%
Q2 2023$4,348
+221.1%
141,431
+276.5%
0.01%
+160.0%
Q1 2023$1,354
-15.1%
37,568
-6.9%
0.01%
-16.7%
Q4 2022$1,594
-99.8%
40,339
+63.9%
0.01%
+50.0%
Q3 2022$989,00024,6070.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders